
The lead
Kerala SMA drug row: Parents spot 'clinical trial' label on generic medicine
A switch from Roche's Evrysdi to the cheaper Natsmart at a Thiruvananthapuram hospital has left parents of children with spinal muscular atrophy asking whether they were told what changed.

